Article Text

COMPARISON OF RECURRENCE AND SURVIVALIN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER TREATED WITH PACLITAXEL AND CISPLATIN VERSUS CISPLATIN/CYCLOPHOSPHAMIDE AS A FIRST LINE CHEMOTHERAPY

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.